192 related articles for article (PubMed ID: 25416028)
1. Human nail plate modifications induced by onychomycosis: implications for topical therapy.
Baraldi A; Jones SA; Guesné S; Traynor MJ; McAuley WJ; Brown MB; Murdan S
Pharm Res; 2015 May; 32(5):1626-33. PubMed ID: 25416028
[TBL] [Abstract][Full Text] [Related]
2. Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.
Cutrín Gómez E; Anguiano Igea S; Delgado-Charro MB; Gómez Amoza JL; Otero Espinar FJ
Eur J Pharm Biopharm; 2018 Jul; 128():48-56. PubMed ID: 29673870
[TBL] [Abstract][Full Text] [Related]
3. Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.
Baswan S; Kasting GB; Li SK; Wickett R; Adams B; Eurich S; Schamper R
Mycoses; 2017 May; 60(5):284-295. PubMed ID: 28098391
[TBL] [Abstract][Full Text] [Related]
4. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
5. Fractional CO
Ortner VK; Nguyen N; Brewer JR; Solovyeva V; Haedersdal M; Philipsen PA
Lasers Surg Med; 2022 Aug; 54(6):861-874. PubMed ID: 35451510
[TBL] [Abstract][Full Text] [Related]
6. Safety assessment for nail cosmetics: Framework for the estimation of systemic exposure through the nail plate.
Yin XJ; Hewitt NJ; Erler S; Bryson P; Blömeke B; Gaspari AA; Goebel C
Regul Toxicol Pharmacol; 2024 Mar; 148():105588. PubMed ID: 38423269
[TBL] [Abstract][Full Text] [Related]
7. Emerging topical onychomycosis therapies - quo vadis?
Elkeeb R; Hui X; Murthy N; Maibach HI
Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
[TBL] [Abstract][Full Text] [Related]
8. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
10. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
Elewski BE; Pollak RA; Pillai R; Olin JT
J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural changes in onychomycosis during the treatment with bifonazole/urea ointment.
Fritsch H; Stettendorf S; Hegemann L
Dermatology; 1992; 185(1):32-6. PubMed ID: 1386263
[TBL] [Abstract][Full Text] [Related]
12. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
13. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
14. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
15. "Endonyx" onychomycosis: a new modality of nail invasion by dermatophytes.
Tosti A; Baran R; Piraccini BM; Fanti PA
Acta Derm Venereol; 1999 Jan; 79(1):52-3. PubMed ID: 10086860
[TBL] [Abstract][Full Text] [Related]
16. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
[TBL] [Abstract][Full Text] [Related]
18. Onychomycosis (trichophyton mentagrophytes). A scanning electron microscopic observation.
Meyer JC; Grundmann HP; Schnyder UW
J Cutan Pathol; 1981 Oct; 8(5):342-53. PubMed ID: 6460792
[TBL] [Abstract][Full Text] [Related]
19. Dermoscopy and Onychomycosis: guided nail abrasion for mycological samples.
Bet DL; Reis AL; Di Chiacchio N; Belda Junior W
An Bras Dermatol; 2015; 90(6):904-6. PubMed ID: 26734877
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic applications of nail clippings.
Stephen S; Tosti A; Rubin AI
Dermatol Clin; 2015 Apr; 33(2):289-301. PubMed ID: 25828720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
